Chien-Ying Wu
Overview
Explore the profile of Chien-Ying Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
A Nonparametric Regression Calibration for the Accelerated Failure Time Model With Measurement Error
Huang Y, Wu C
Stat Med
. 2024 Dec;
43(30):6073-6085.
PMID: 39638328
Accelerated failure time models are appealing due to their intuitive interpretation. However, when covariates are subject to measurement errors, naive estimation becomes severely biased. To address this issue, the regression...
2.
Lu C, Lu C, Chang K, Chun-Li W, Wu C
Aging Clin Exp Res
. 2024 Sep;
36(1):193.
PMID: 39311977
Background: Colorectal cancer (CRC) is a significant health concern, particularly among older adults. Outcomes between laparoscopic and robot-assisted surgeries for right-sided colon cancers in the oldest old population have yet...
3.
Suk F, Wu C, Fang C, Chen T, Liao Y
Biomed Pharmacother
. 2023 Aug;
166:115293.
PMID: 37567069
Hepatocellular carcinoma (HCC) is the most common primary malignant tumor. Although sorafenib and regorafenib have been approved for first-line and second-line treatment, respectively, of patients with advanced HCC, long-term treatment...
4.
Suk F, Wu C, Chiu W, Chien C, Chen T, Liao Y
Molecules
. 2022 Nov;
27(22).
PMID: 36432116
Primary liver cancer is the fifth leading death of cancers in men, and hepatocellular carcinoma (HCC) accounts for approximately 90% of all primary liver cancer cases. Sorafenib is a first-line...
5.
Wu C, Cheng K, Chen Y, Lu C, Lin Y
Int J Colorectal Dis
. 2022 Apr;
37(5):1189-1197.
PMID: 35476135
Purpose: NSAIDs are commonly used as opioid-sparing analgesics in colorectal surgery. Many efforts are made to elucidate the risk of NSAID-associated anastomotic leakage after colorectal surgery. However, these results still...
6.
Suk F, Wang Y, Chiu W, Liu C, Wu C, Chen T, et al.
Int J Mol Sci
. 2021 Aug;
22(16).
PMID: 34445279
Hepatocellular carcinoma (HCC) is the most common primary malignant tumor in the world. Sorafenib is the first-line drug for patients with advanced HCC. However, long-term treatment with sorafenib often results...
7.
Liao Y, Wang Y, Wu C, Hsu F, Chien C, Lee Y
Int J Mol Sci
. 2021 Apr;
22(6).
PMID: 33805788
Persistent chronic liver diseases increase the scar formation and extracellular matrix accumulation that further progress to liver fibrosis and cirrhosis. Nevertheless, there is no antifibrotic therapy to date. The ketogenic...